Diagnostic Yield From a Nationwide Implementation of Precision Medicine for all Children With Cancer

Abstract

Up-front, large-scale genomic characterization of pediatric solid malignancies provides diagnostically valuable data in the majority of patients also in a largely unselected cohort.